909391-53-3

Basic information

• Product Name: 5-fluoro-N-[2-(isopropylamino)-2-oxo-ethyl]-2-nitro-benzamide
• CAS NO: 909391-53-3
• Molecular Formula: C₁₂H₁₄FN₃O₄
• Molecular Weight: 283.2556632
• Mol File: 909391-53-3.mol

Chemical Properties

• CAS DataBase Reference: 5-fluoro-N-[2-(isopropylamino)-2-oxo-ethyl]-2-nitro-benzamide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-fluoro-N-[2-(isopropylamino)-2-oxo-ethyl]-2-nitro-benzamide(909391-53-3)
• EPA Substance Registry System: 5-fluoro-N-[2-(isopropylamino)-2-oxo-ethyl]-2-nitro-benzamide(909391-53-3)

Safety Data

• Hazardous Substances Data: 909391-53-3(Hazardous Substances Data)

Upstream product

• 320-98-9 5-fluoro-2-nitrobenzoic acid 
• 394-02-5 5-fluoro-2-nitrobenzoyl chloride 
• 67863-05-2 2-amino-N-isopropylacetamide 

Downstream Products

• 1290633-87-2 (1S,4S)-tert-butyl 5-(3-(2-(isopropylamino)-2-oxoethylcarbamoyl)-4-nitrophenyl)-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate 
• 1290633-68-9 5-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-N-(2-(isopropylamino)-2-oxoethyl)-2-nitrobenzamide 
• 1290634-18-2 5-((1S,4S)-2,5-diazabicyclo[2.2.1]heptan-2-yl)-N-(2-(isopropylamino)-2-oxoethyl)-2-nitrobenzamide 
• 1019971-36-8 2-amino-5-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-N-(2-(isopropylamino)-2-oxoethyl)benzamide 
• 1290634-61-5 2-(6-(1,4-diazabicyclo[3.2.2]nonan-4-yl)-2-(3-chloro-5-fluorophenyl)-4-oxoquinazolin-3(4H)-yl)-N-isopropylacetamide 
• 909391-54-4 N-(isopropylcarbamoylmethyl)-5-methyl-[(4-methoxybenzyl)(3-piperidin-1-ylpropyl)amino]-2-nitrobenzamide 
• 1012784-26-7 N-(isopropylcarbamoylmethyl)-5-(4-methylperhydro-1,4-diazepin-1-yl)-2-nitrobenzamide 

Relevant articles and documents

CONDENSED AZINE - DERIVATIVES FOR THE TREATMENT OF DISEASES RELATED TO THE ACETYLCHOLINE RECEPTOR

The present invention relates to a heterocyclic derivative of formula (I) wherein the variables are as defined in the specification or to a pharmaceutically acceptable salt or solvate thereof. The present invention further relates to pharmaceutical compositions comprising said heterocyclic derivatives and to their use in therapy, for instance in the treatment or prevention of disorders mediated by nicotinic acetylcholine receptors, such as schizophrenia and Alzheimer's disease.

2- (4-0X0-4H-QUINAZ0LIN-3-YL) ACETAMIDES AND THEIR USE AS VASOPRESSIN V3 ANTAGONISTS

The present invention relates to 2-(4-oxo4H-quinazolin-3-yl)acetamicle derivatives of formula (I), and to their use as vasopressin V3 antagonists, particularly for the treatment of depression.